表紙
市場調査レポート

大動脈弁狭窄症 (AS) :主要16市場の予測 2015-2025年

Aortic Stenosis Forecast In 16 Major Markets 2015 -2025

発行 Black Swan Analysis 商品コード 345870
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
大動脈弁狭窄症 (AS) :主要16市場の予測 2015-2025年 Aortic Stenosis Forecast In 16 Major Markets 2015 -2025
出版日: 2015年12月01日 ページ情報: 英文 66 Pages
概要

大動脈弁狭窄症 (AS) は、大動脈弁の狭窄を生じる大動脈弁面積の閉塞又は損失です。現在ASは西欧諸国における最も一般的な弁膜心疾患の形態であると考えられています。

当レポートでは、主要16市場 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本、トルコ、メキシコ、カナダ、オーストラリア、フィンランド、ポーランド、アルゼンチンおよび中国) における大動脈弁狭窄症の現在の患者数 (性別、年齢コホート別) について調査分析し、現在の有病率のほか、疾患の概要、危険因子、疾患の診断と予後、主な症状や合併症など、体系的な情報を提供しています。

図表

イントロダクション

病因

危険因子と予防

疾患の診断

変異:地域/民族別

疾患予後と臨床経過

疾患に関連する主な合併症/特徴

患者数を定量化する手法

  • 追加データ

大動脈弁狭窄症の有病率トップライン

大動脈弁狭窄症患者の特徴

  • 大動脈弁狭窄症の重症度
  • 大動脈弁狭窄症の原因論

大動脈弁狭窄症のNYHA分類 (心機能分類)

  • 軽度
  • 重度

重度大動脈弁狭窄症における症候性 vs. 無症候性

重度症候性大動脈弁狭窄症関連の合併症

略語

関連出版

患者ベースのオンラインデータベース

患者ベースの製品

価格のオンラインデータ・プラットフォーム

参考文献

付録

目次
Product Code: AOST0011115

image1

Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. Currently, AS is thought to be the most common form of valvular heart disease in Western countries. This report provides the current prevalent population for AS across 16 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Turkey, Mexico, Canada, Australia, Finland, Poland, Argentina and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the risk factors, aetiology, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of AS have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Aortic Stenosis include:

  • Previous myocardial infarct / Angina
  • Carotid atherosclerosis
  • COPD
  • Lower limb atherosclerosis
  • Atrial fibrillation
  • Heart failure

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global AS's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of AS and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on AS's prevalent population.
  • Identify sub-populations within AS which require treatment.
  • Gain an understanding of the specific markets that have the largest number of AS patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR, CN, PL, TR, CA, AU, AR, MX

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

  • Management of Aortic Valve Stenosis

Key Co-morbid Conditions/ Features Associated with the Disease

Methodology for Quantification of Patient Numbers

  • Additional data

Top-Line Prevalence for Aortic Stenosis

Features of Aortic Stenosis Patients

  • Severity of Aortic Stenosis
  • Aetiology of Aortic Stenosis

Aortic Stenosis by NYHA Class

  • Moderate Aortic Stenosis by NYHA Class
  • Severe Aortic Stenosis by NYHA Class

Symptomatic vs. Asymptomatic in Severe Aortic Stenosis

Associated Co-morbid Conditions of Severe Symptomatic Aortic Stenosis

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • Classification of Aortic Stenosis severity
  • ESC guidelines for management of Aortic Valve Stenosis
  • ACC/AHA guidelines for management of Aortic Valve Stenosis
  • Prevalence of Aortic Stenosis, total (000s)
  • Prevalence of Aortic Stenosis, males (000s)
  • Prevalence of Aortic Stenosis, females (000s)
  • Severity of stenosis in Aortic Stenosis patients, total (000s)
  • AS patients by main aetiology, total (000s)
  • Moderate AS patients by NYHA Class, total (000s)
  • Severe AS patients by NYHA Class, total (000s)
  • Symptomatic vs. asymptomatic in Severe Aortic Stenosis patients, total (000s)
  • Prevalence of Diabetes in Severe Symptomatic AS patients, total (000s)
  • Prevalence of Dyslipidaemia in Severe Symptomatic AS patients, total (000s)
  • Prevalence of Hypertension in Severe Symptomatic AS patients, total (000s)
  • Prevalence of COPD in Severe Symptomatic AS patients, total (000s)
  • Prevalence of Atrial Fibrillation in Severe Symptomatic AS patients, total (000s)
  • Severe Symptomatic AS patients with a history of MI, total (000s)
  • Prevalence of Carotid Artery Atherosclerosis in Severe Symptomatic AS patients, total (000s)
  • Lower Limb Atherosclerosis in Severe Symptomatic AS patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • USA Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • France Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • France Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Germany Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Italy Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Spain Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Turkey Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Turkey Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Mexico Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Mexico Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Canada Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Canada Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Australia Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Australia Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Finland Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Finland Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Poland Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Poland Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • Argentina Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • Argentina Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
  • China Prevalence of Aortic Stenosis by 5-yr age cohort, males (000s)
  • China Prevalence of Aortic Stenosis by 5-yr age cohort, females (000s)
Back to Top